Open access
Jul 2026
Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer
Combining this CuZnS@BSA nanoregulator with PD-L1 blockade led to potent suppression of both subcutaneous tumor growth and lung metastasis, thus providing a direct, elegant link between metabolic reprogramming and systemic immune activation for TNBC therapy.
Jingyi Yang, Qi Li, Pi Zhao et al.
· Theranostics · 0 citations